COVID-19 and IFIs

Call for Cases of Challenging Invasive Fungal Infections

Do you have an interesting case of an IFI in a patient with COVID-19? Or a challenging case of candidiasis or endemic mycoses? Please consider sending your case to us.  We are compiling a range of cases for discussion that illustrate diagnostic and management challenges for these difficult infections. Select cases will be workshopped by our expert faculty.

Care Step Pathway for a Suspected Pulmonary COVID-19-Associated IFI

The primary goal of this initiative is educating and preparing clinical providers and public health workers to address the needs of the population of COVID-19 patients most seriously compromised by the disease, specifically those with respiratory failure requiring mechanical ventilation who are at risk for or who subsequently develop COVID-19-associated pulmonary aspergillosis (CAPA) or other COVID-19-associated invasive fungal infections (CA-IFIs).

COVID-19-associated Invasive Fungal Infection – OFID publication

Published as an editor’s choice article in Open Forum Infectious Diseases on November 16, 2021, COVID-19-associated Invasive Fungal Infection was written by faculty members of the COVID-19-associated Fungal Infections Educational Initiative as well as a medical epidemiologist from the Center for Disease Control and Prevention (Brendan Jackson, MD, MPH). Under the leadership of John W. Baddley, MD, and George R. Thompson, III, MD, the authors addressed a range of salient topics.

Resistant Dermatophyte Infographic

Dermatophyte resistance is a growing problem throughout the world. It’s important to be aware of the problem and to institute appropriate testing and tailored treatment to address this issue. We have created this infographic to inform both health care providers and patients about resistant dermatophytes.

Mucormycosis Infographic

COVID-19-associated mucormycosis has ravaged India.  With an eye toward early recognition and treatment, we have created this infographic to inform both healthcare providers and patients about mucormycosis.

The MRC CMM would like to invite you to their quarterly Myco-Clinics, where clinical experts in Medical Mycology will be presenting cases highlighting the challenges and new observations in the clinical recognition, diagnosis and management of fungal diseases.

Ahmed Fahal: Pulmonary metastatic eumycetoma an unusual complication: Case series and literature review.

17 June 2022, 16:00 BST, 8:00 PDT, 10:00 CDT, 11:00 EDT

CDC Fellowship related to antifungal resistance with the Mycotic Diseases Branch (MDB)

The Mycotic Diseases Branch (MDB) has three exciting training opportunities for qualified candidates.  This is being offer through the Oak Ridge Associated Universities – ORAU.

Opportunities are as follows:

• Fungal Identification and Susceptibility Testing Training

https://www.zintellect.com/Opportunity/Details/CDC-DFWED-2022-0131

• Drug-resistant Fungi Epidemiologic Data Analyses

https://www.zintellect.com/Opportunity/Details/CDC-DFWED-2022-0132

• Understanding Emergence of Azole-resistant Aspergillus Fumigatus in the U.S.

https://www.zintellect.com/Opportunity/Details/CDC-DFWED-2022-0133

Opportunities are open to the public for recent STEM graduates.  Application period is open now through 5/23/22 @ 3:00pm.

Direct all questions to MDB Workforce (CDC) MDBWorkforce@cdc.gov.

Coming soon! Algorithms for management of endemic mycoses